Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age.
Tapia, Milagritos D
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age. [electronic resource] - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Nov 2015 - S514-20 p. digital
Publication Type: Clinical Trial; Journal Article
1537-6591
10.1093/cid/civ672 doi
Africa
Animals
Antibodies, Bacterial--blood
Blood Bactericidal Activity
Complement System Proteins
Enzyme-Linked Immunosorbent Assay
Female
Follow-Up Studies
Humans
Immunoglobulin G--blood
Infant
Male
Meningococcal Vaccines--administration & dosage
Rabbits
Time Factors
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age. [electronic resource] - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Nov 2015 - S514-20 p. digital
Publication Type: Clinical Trial; Journal Article
1537-6591
10.1093/cid/civ672 doi
Africa
Animals
Antibodies, Bacterial--blood
Blood Bactericidal Activity
Complement System Proteins
Enzyme-Linked Immunosorbent Assay
Female
Follow-Up Studies
Humans
Immunoglobulin G--blood
Infant
Male
Meningococcal Vaccines--administration & dosage
Rabbits
Time Factors